These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38483956)

  • 1. The prognostic impact of follow-up cardiac metaiodobenzylguanidine imaging on left ventricular trajectory after acute decompensation.
    Kayama K; Yamada T; Seo M; Watanabe T; Morita T; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2024 Jul; 25(8):1144-1154. PubMed ID: 38483956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR).
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
    Kasama S; Toyama T; Sumino H; Nakazawa M; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2008 Jun; 49(6):907-14. PubMed ID: 18483106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Cardiac
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Kayama K; Kawahira M; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):655-668. PubMed ID: 34656490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co-morbid burden in acute decompensated heart failure.
    Kayama K; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Seo M; Nakamura J; Kawahira M; Fukunami M
    ESC Heart Fail; 2021 Apr; 8(2):1167-1177. PubMed ID: 33438366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of left ventricular global longitudinal strain with cardiac autonomic denervation as assessed by
    Cruz MC; Abreu A; Portugal G; Santa-Clara H; Cunha PS; Oliveira MM; Santos V; Oliveira L; Rio P; Rodrigues I; Morais LA; Ferreira RC; Carmo MM
    J Nucl Cardiol; 2019 Jun; 26(3):869-879. PubMed ID: 29209951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
    Doi T; Nakata T; Yuda S; Hashimoto A
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
    Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N
    J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.
    Tamaki S; Yamada T; Okuyama Y; Morita T; Sanada S; Tsukamoto Y; Masuda M; Okuda K; Iwasaki Y; Yasui T; Hori M; Fukunami M
    J Am Coll Cardiol; 2009 Feb; 53(5):426-35. PubMed ID: 19179201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.
    Tamaki S; Yamada T; Watanabe T; Morita T; Kawasaki M; Kikuchi A; Kawai T; Seo M; Nakamura J; Kayama K; Sakamoto D; Ueda K; Kogame T; Tamura Y; Fujita T; Nishigaki K; Fukuda Y; Kokubu Y; Fukunami M
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1906-1917. PubMed ID: 34997293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
    Agostini D; Verberne HJ; Burchert W; Knuuti J; Povinec P; Sambuceti G; Unlu M; Estorch M; Banerjee G; Jacobson AF
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):535-46. PubMed ID: 18043919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cardiac metaiodobenzylguanidine imaging and QRS duration in implantable cardioverter defibrillator patients with and without heart failure.
    Kawasaki M; Yamada T; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kikuchi A; Kawai T; Seo M; Hirota Kida ; Sakata Y; Fukunami M
    Int J Cardiol; 2019 Dec; 296():164-171. PubMed ID: 31371118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.
    Leosco D; Parisi V; Pellegrino T; Pagano G; Femminella GD; Bevilacqua A; Paolillo S; Formisano R; Ferro G; de Lucia C; Prastaro M; Filardi PP; Cuocolo A; Rengo G; Ferrara N
    Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1601-11. PubMed ID: 25947572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
    García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic usefulness of planar
    Agostini D; Ananthasubramaniam K; Chandna H; Friberg L; Hudnut A; Koren M; Miyamoto MI; Senior R; Shah M; Travin MI; Dahl JV; Chen K; Levy WC;
    J Nucl Cardiol; 2021 Aug; 28(4):1490-1503. PubMed ID: 31468379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.